Published in AIDS on January 05, 2001
The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS (2009) 3.78
Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr (2009) 2.99
Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med (2004) 2.72
HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis (2009) 2.00
Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J (2006) 1.88
The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved (2013) 1.75
Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis (2007) 1.70
Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population. BMC Public Health (2010) 1.63
The lifetime medical cost savings from preventing HIV in the United States. Med Care (2015) 1.61
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV. AIDS (2008) 1.59
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial. Clin Infect Dis (2007) 1.57
Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya. AIDS Behav (2012) 1.43
Delayed presentation for human immunodeficiency virus (HIV) care among veterans: a problem of access or screening? Med Care (2007) 1.32
Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: a case-case comparison. AIDS Res Ther (2008) 1.30
Prevalence of primary HIV infection in symptomatic ambulatory patients. Ann Fam Med (2005) 1.27
Using the HIV surveillance system to monitor the National HIV/AIDS Strategy. Am J Public Health (2012) 1.27
Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis (2013) 1.24
Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007. BMC Infect Dis (2011) 1.18
Determinants and prevalence of late HIV testing in Tijuana, Mexico. AIDS Patient Care STDS (2010) 1.08
Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV. BMJ Open (2013) 1.07
Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy. Am J Public Health (2009) 1.05
Contributions to early HIV diagnosis among patients linked to care vary by testing venue. BMC Public Health (2008) 1.05
Barriers and facilitators to HIV testing and linkage to primary care: narratives of people with advanced HIV in the Southeast. AIDS Care (2009) 1.05
HIV testing of at risk patients in a large integrated health care system. J Gen Intern Med (2007) 1.03
Improving HIV/AIDS care through treatment advocacy: going beyond client education to empowerment by facilitating client-provider relationships. AIDS Care (2011) 1.01
Engaging HIV-positive individuals in specialized care from an urban emergency department. AIDS Patient Care STDS (2011) 0.98
Improving outcomes in state AIDS drug assistance programs. J Acquir Immune Defic Syndr (2009) 0.96
HIV/AIDS: AIDS Drug Assistance Programs in the era of routine HIV testing. Clin Infect Dis (2008) 0.95
Linkage to care for HIV-infected heterosexual men in the United States. Clin Infect Dis (2011) 0.95
HIV Testing among Adolescents and Youth in the United States: Update from the 2009 Behavioral Risk Factor Surveillance System. Open AIDS J (2011) 0.91
Seasonal variation in undiagnosed HIV infection on the general medicine and trauma services of two urban hospitals. J Gen Intern Med (2005) 0.91
Social support and delays seeking care after HIV diagnosis, North Carolina, 2000-2006. AIDS Care (2009) 0.87
A simple method for estimating the prevalence of undiagnosed HIV infection in an emergency department. Ann Emerg Med (2011) 0.85
Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development. HIV Clin Trials (2012) 0.84
Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis. Value Health (2010) 0.83
Causes of hospitalization and perceived access to care among persons newly diagnosed with HIV infection: implications for HIV testing programs. AIDS Patient Care STDS (2011) 0.83
Implications and impact of the new US Centers for Disease Control and prevention HIV testing guidelines. Curr Infect Dis Rep (2008) 0.83
Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res (2016) 0.83
Impact of hepatitis C on HIV progression in adults with alcohol problems. Alcohol Clin Exp Res (2007) 0.82
Late diagnosis of HIV infection at two academic medical centers: 1994-2004. AIDS Care (2008) 0.82
Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD. AIDS Res Hum Retroviruses (2015) 0.81
Predictors of Late HIV Diagnosis among Adult People Living with HIV/AIDS Who Undertake an Initial CD4 T Cell Evaluation, Northern Ethiopia: A Case-Control Study. PLoS One (2015) 0.80
Undiagnosed hepatitis C on the general medicine and trauma services of two urban hospitals. J Infect (2009) 0.79
'Slipping through the cracks': policy implications of delays in HIV treatment seeking. Glob Public Health (2012) 0.79
Missed opportunities: refusal to confirm reactive rapid HIV tests in the emergency department. PLoS One (2013) 0.78
Factors associated with late presentation for HIV/AIDS care in Harare City, Zimbabwe, 2015. BMC Public Health (2016) 0.78
Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy. Eur J Clin Microbiol Infect Dis (2003) 0.78
A budget impact analysis of rapid human immunodeficiency virus screening in Veterans Administration emergency departments. J Emerg Med (2011) 0.78
Linking Infectious and Narcology Care (LINC) in Russia: design, intervention and implementation protocol. Addict Sci Clin Pract (2016) 0.78
Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department. PLoS One (2011) 0.78
Psychosocial Stressors and Alcohol Use, Severity, and Treatment Receipt across HIV Status in a Nationally Representative Sample of U.S. Residents. Subst Abus (2016) 0.77
Alcohol and associated characteristics among older persons living with human immunodeficiency virus on antiretroviral therapy. Subst Abus (2014) 0.76
Differences in risk behaviours, HIV/STI testing and HIV/STI prevalence between men who have sex with men and men who have sex with both men and women in China. Int J STD AIDS (2015) 0.76
Predictors of Linkage to Care for Newly Diagnosed HIV-Positive Adults. West J Emerg Med (2015) 0.75
The Role of Patient Navigators in Building a Medical Home for Multiply Diagnosed HIV-Positive Homeless Populations. J Public Health Manag Pract (2017) 0.75
Opportunities for earlier HIV diagnosis in a pediatric ED. Am J Emerg Med (2015) 0.75
A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: impact on alcohol use, general functional ability, quality of life and adherence to HAART. BMC Psychiatry (2017) 0.75
Factors Associated with Delayed Enrollment in HIV Medical Care among HIV-Positive Individuals in Odessa Region, Ukraine. J Int Assoc Provid AIDS Care (2016) 0.75
HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013. Open AIDS J (2016) 0.75
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA (2001) 17.91
Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med (1998) 3.45
Fee-for-time system. A conceptual framework for an incentive-neutral method of physician payment. JAMA (1993) 3.39
CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity (2000) 3.28
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord (2003) 3.23
Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol (1995) 2.87
The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care (1999) 2.85
Curbside consultation practices and attitudes among primary care physicians and medical subspecialists. JAMA (1998) 2.70
Sexual ethics. Disclosure of HIV-positive status to partners. Arch Intern Med (1998) 2.67
"Inappropriate" emergency department use: a comparison of three methodologies for identification. Acad Emerg Med (1996) 2.55
Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med (2000) 2.54
Studies on a phytohemagglutinin from the lentil. II. Multiple forms of Lens culinaris hemagglutinin. J Biol Chem (1971) 2.52
Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness. Ann Intern Med (2001) 2.47
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA (1999) 2.35
Molecular analyses of in vivo hprt mutations in human T-lymphocytes. I. Studies of low frequency 'spontaneous' mutants by Southern blots. Mutagenesis (1987) 2.33
Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol (1997) 2.32
Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med (2000) 2.21
Sex differences in academic advancement. Results of a national study of pediatricians. N Engl J Med (1996) 2.20
Who leaves against medical advice? J Gen Intern Med (1995) 1.89
PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet (1997) 1.84
Generation and analysis of mice lacking the chemokine fractalkine. Mol Cell Biol (2001) 1.79
Use of the ED as a regular source of care: associated factors beyond lack of health insurance. Ann Emerg Med (1997) 1.75
Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn (2002) 1.74
Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med (2001) 1.73
Women in academic emergency medicine. Acad Emerg Med (2000) 1.70
Interest in smoking cessation among injection drug users. Am J Addict (2001) 1.70
The care of older persons with diabetes mellitus: families and primary care physicians. J Am Geriatr Soc (1996) 1.67
Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. S Afr Med J (2006) 1.67
Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res (2002) 1.60
Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med (1997) 1.59
Depression among needle exchange program and methadone maintenance clients. J Subst Abuse Treat (2000) 1.58
Positive Epstein-Barr virus heterophile antibody tests in patients with primary human immunodeficiency virus infection. Am J Med (2001) 1.43
Limits of patient autonomy. Physician attitudes and practices regarding life-sustaining treatments and euthanasia. Arch Intern Med (1993) 1.40
Breast cancer care in older women: sources of information, social support, and emotional health outcomes. Cancer (1998) 1.40
An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts. Cell (1986) 1.35
Prevalence of depressive and alcohol abuse symptoms among women VA outpatients who report experiencing sexual assault while in the military. J Trauma Stress (1999) 1.34
Medical profile of women Veterans Administration outpatients who report a history of sexual assault occurring while in the military. J Womens Health Gend Based Med (1999) 1.33
Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of the literature. Medicine (Baltimore) (1991) 1.31
HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors. J Gen Intern Med (1998) 1.30
Late presentation for HIV care in central Haiti: factors limiting access to care. AIDS Care (2007) 1.30
High-risk profiles for nursing home admission. Gerontologist (1992) 1.29
A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med (1995) 1.27
Linkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi Township, Durban, South Africa. HIV Med (2013) 1.25
Prevalence and predictors of unmet need for supportive services among HIV-infected persons: impact of case management. Med Care (2000) 1.24
The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med (1999) 1.22
Social relationships and intravenous drug use among methadone maintenance patients. Drug Alcohol Depend (2001) 1.19
Screening for acute HIV infection in South Africa: finding acute and chronic disease. HIV Med (2011) 1.19
Serum amyloid A to monitor cancer dissemination. Ann Intern Med (1979) 1.16
Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts. Int J Epidemiol (2001) 1.15
Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis (1987) 1.14
Validation of the screening strategy in the NIAAA "Physicians' Guide to Helping Patients with Alcohol Problems". J Stud Alcohol (2001) 1.13
Alcohol abuse and dependence in Latinos living in the United States: validation of the CAGE (4M) questions. Arch Intern Med (1999) 1.13
Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells. Proc Natl Acad Sci U S A (1987) 1.13
Factors associated with initiation of primary medical care for HIV-infected persons. Am J Med (1994) 1.12
Adverse drinking consequences among alcohol abusing intravenous drug users. Alcohol Clin Exp Res (2001) 1.11
The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. J Viral Hepat (2010) 1.11
Comparing the health status of male and female veterans who use VA health care: results from the VA Women's Health Project. Women Health (1999) 1.11
Linkage to medical services in the Drug Abuse Treatment Outcome Study. Med Care (2001) 1.07
Routine, voluntary HIV testing in Durban, South Africa: correlates of HIV infection. HIV Med (2008) 1.07
Neurobehavioral functioning in asymptomatic HIV-1 infected women. J Int Neuropsychol Soc (1998) 1.03
Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis. Clin Infect Dis (2002) 1.03
Patterns of proton pump inhibitor use in clinical practice. Am J Med (2001) 1.02
Physicians' utilization of health care. J Gen Intern Med (1995) 1.01
Studies on a phytohemagglutinin from the lentil. IV. Direct binding studies of Lens culinaris hand myoglobin derivatives. Arch Biochem Biophys (1971) 1.01
How important is functional status as a predictor of service use by older people? J Aging Health (1990) 1.01
Informal care for frail elders: the role of secondary caregivers. Gerontologist (1989) 1.00
The doctor-patient relationship and HIV-infected patients' satisfaction with primary care physicians. J Gen Intern Med (2000) 1.00
Failure of TPN supplementation to improve liver function, immunity, and mortality in thermally injured patients. J Trauma (1987) 0.99
A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection. Med Decis Making (1998) 0.99
Natural killer cell defects resulting from thermal injury. Cell Immunol (1984) 0.98
Longitudinal study of the in vivo hprt mutant frequency in human T-lymphocytes as determined by a cell cloning assay. Environ Mol Mutagen (1989) 0.98
IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils. Clin Exp Immunol (1995) 0.97
Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. Am J Med (2001) 0.97
Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody. Clin Infect Dis (2001) 0.96
Defective NK cell activity following thermal injury. Clin Exp Immunol (1986) 0.96
Transportation and retention in outpatient drug abuse treatment programs. J Subst Abuse Treat (2001) 0.95
Physical symptoms and depressive symptoms among individuals with HIV infection. Psychosomatics (1992) 0.94
Management of hospitalized intravenous drug users: role of the internist. Am J Med (1994) 0.92
The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach. HIV Med (2007) 0.92
Coronary heart disease risk in men and the epidemic of overweight and obesity. Int J Obes (Lond) (2005) 0.91
The effect of GM-CSF and G-CSF on human neutrophil function. Immunopharmacology (1995) 0.91
Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users. Epidemiol Infect (2005) 0.90
The effects of colony stimulating factors on human monocyte cell function. Int J Immunopharmacol (1995) 0.89
Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA. HIV Med (2011) 0.89
Molecular analyses of in vivo hypoxanthine-guanine phosphoribosyltransferase mutations in human T-lymphocytes: II. Demonstration of a clonal amplification of hprt mutant T-lymphocytes in vivo. Environ Mol Mutagen (1988) 0.89
Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. Mutat Res (1993) 0.89
In vivo hprt mutant frequencies in T-cells of normal human newborns. Mutat Res (1990) 0.89
AIDS among the homeless of Boston: a cohort study. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.88
Do internists and emergency physicians agree on the appropriateness of emergency department visits? J Gen Intern Med (1997) 0.87
Evolution of depressive symptoms in human immunodeficiency virus-infected patients entering primary care. J Nerv Ment Dis (2001) 0.87
Clinical evaluation of a biodegradable collagen membrane in guided tissue regeneration. J Periodontol (1990) 0.87
Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults. Am J Public Health (2001) 0.87
Perceived needs and unmet needs for formal services among people with HIV disease. J Community Health (1993) 0.87